PLA2G6 (phospholipase A2 group VI)

2007-02-01  

Identity

HGNC
LOCATION
22q13.1
LOCUSID
ALIAS
CaI-PLA2,GVI,INAD1,IPLA2-VIA,NBIA2,NBIA2A,NBIA2B,PARK14,PLA2,PNPLA9,iPLA2,iPLA2beta
FUSION GENES

Other Information

Locus ID:

NCBI: 8398
MIM: 603604
HGNC: 9039
Ensembl: ENSG00000184381

Variants:

dbSNP: 8398
ClinVar: 8398
TCGA: ENSG00000184381
COSMIC: PLA2G6

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000184381ENST00000332509O60733
ENSG00000184381ENST00000335539O60733
ENSG00000184381ENST00000402064O60733
ENSG00000184381ENST00000427114H0Y6T3
ENSG00000184381ENST00000430886B0QYE9
ENSG00000184381ENST00000436218F8WEN3
ENSG00000184381ENST00000448094E7EX67
ENSG00000184381ENST00000452542H0Y7G5
ENSG00000184381ENST00000454670H7C3P5
ENSG00000184381ENST00000455341F8WEQ9
ENSG00000184381ENST00000498338M0R1Q9
ENSG00000184381ENST00000594306M0R3D9
ENSG00000184381ENST00000655142A0A590UK67
ENSG00000184381ENST00000660610O60733
ENSG00000184381ENST00000663895O60733
ENSG00000184381ENST00000664587A0A590UJC7
ENSG00000184381ENST00000665987A0A590UJH4
ENSG00000184381ENST00000667521O60733
ENSG00000184381ENST00000668499A0A590UJZ2
ENSG00000184381ENST00000668949A0A590UK51

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Glycerophospholipid metabolismKEGGko00564
Ether lipid metabolismKEGGko00565
Arachidonic acid metabolismKEGGko00590
Linoleic acid metabolismKEGGko00591
alpha-Linolenic acid metabolismKEGGko00592
Glycerophospholipid metabolismKEGGhsa00564
Ether lipid metabolismKEGGhsa00565
Arachidonic acid metabolismKEGGhsa00590
Linoleic acid metabolismKEGGhsa00591
alpha-Linolenic acid metabolismKEGGhsa00592
Vascular smooth muscle contractionKEGGhsa04270
Vascular smooth muscle contractionKEGGko04270
Fc gamma R-mediated phagocytosisKEGGko04666
Fc gamma R-mediated phagocytosisKEGGhsa04666
Metabolic pathwaysKEGGhsa01100
Ras signaling pathwayKEGGhsa04014
Inflammatory mediator regulation of TRP channelsKEGGhsa04750
Inflammatory mediator regulation of TRP channelsKEGGko04750
Immune SystemREACTOMER-HSA-168256
Innate Immune SystemREACTOMER-HSA-168249
Fcgamma receptor (FCGR) dependent phagocytosisREACTOMER-HSA-2029480
Role of phospholipids in phagocytosisREACTOMER-HSA-2029485
Vesicle-mediated transportREACTOMER-HSA-5653656
Membrane TraffickingREACTOMER-HSA-199991
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Phospholipid metabolismREACTOMER-HSA-1483257
Glycerophospholipid biosynthesisREACTOMER-HSA-1483206
Acyl chain remodelling of PEREACTOMER-HSA-1482839
Acyl chain remodelling of PCREACTOMER-HSA-1482788
Acyl chain remodeling of CLREACTOMER-HSA-1482798
Intra-Golgi and retrograde Golgi-to-ER trafficREACTOMER-HSA-6811442
Golgi-to-ER retrograde transportREACTOMER-HSA-8856688
COPI-independent Golgi-to-ER retrograde trafficREACTOMER-HSA-6811436

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA449552etoposideChemicalMultilinkAnnotationassociated24444404

References

Pubmed IDYearTitleCitations
153649292004Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.261
167833782006PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron.130
185703032009Characterization of PLA2G6 as a locus for dystonia-parkinsonism.101
195783652009Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.94
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.85
187997832008Neurodegeneration associated with genetic defects in phospholipase A(2).83
187997832008Neurodegeneration associated with genetic defects in phospholipase A(2).83
206693272010Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.67
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.62
122088802002I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation.60

Citation

Dessen P

PLA2G6 (phospholipase A2 group VI)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45836/pla2g6